Gadoquatrane showed pediatric safety and pharmacokinetic profiles similar to adults in a study, supporting use as a low-dose ...

A specially coated iron oxide nanoparticle could provide an alternative to conventional gadolinium-based contrast agents used for magnetic resonance imaging (MRI). In rare cases, the currently used ...

To produce sharper images of organs through magnetic resonance imaging, doctors and researchers often inject patients with so-called contrast agents. The most commonly used agents contain the metal ...

Researchers have taken a key step forward in developing a new, possibly safer contrast agent for use in MRI exams. Researchers at Massachusetts General Hospital (MGH) have taken a key step forward in ...

GE HealthCare has announced positive results from a Phase I study of its manganese-based macrocyclic magnetic resonance imaging (MRI) contrast agent. Data from the first-in-human trial – presented at ...

Contrast agents used in X-ray and other methods of imaging could increase the risk of developing dementia by 2.09 times, researchers said yesterday. Contrast agents are widely used in clinical testing ...

A review of cases using MRI with and without contrast agent found perfect or near-perfect agreement in most cases when evaluating patients with short stature for growth hormone deficiency. Gadolinium ...

Nephropathy induced by exposure to radiocontrast agents, a possible complication of percutaneous coronary interventions, is associated with significant in-hospital and long-term morbidity and ...

FDA-approved iron oxide nanocrystals (IONs) as negative magnetic resonance imaging (MRI) contrast agents are experiencing obstacles due to their low relaxation rate and coherent ferromagnetism. Though ...